Talaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ tran…

Biotechnology
US, Louisville [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Talaris Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Talaris Therapeutics, Inc. can't present revenue by segment

End of TALS's Analysis
CIK: - CUSIP: 87410C104 LEI: - UEI: -
Secondary Listings
TALS has no secondary listings inside our databases.